# Ascendis Pharma
 (stock symbol: ASND) Logo in transparent PNG format

## Ascendis Pharma
 Logo large

### Ascendis Pharma
 Logo large Download PNG (44.02 KB)

![Ascendis Pharma
 Logo large Download PNG (44.02 KB)](/img/orig/ASND_BIG-30478c3e.png)

## Ascendis Pharma
 Logo icon format

### Ascendis Pharma
 Logo icon format Download PNG (37.25 KB)

![Ascendis Pharma
 Logo icon format Download PNG (37.25 KB)](/img/orig/ASND-85d208d8.png)

## About Ascendis Pharma


Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ÃŸ/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

1. Website domain: ascendispharma.com
2. Employees: 639
3. Marketcap: $3.99 Billion USD


## Categories
- [x] ðŸ‡©ðŸ‡° Denmark
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
